Search results
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo Finance· 4 days agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com
Investing.com· 5 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed as...
Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies
Reuters· 5 days agoLike other...
What NC Gov. Cooper says about the economy and politics after European recruitment trip
Durham Herald-Sun McClatchy via AOL· 1 hour agoCooper traveled to France, Germany and Switzerland and met with Schneider Electric, Syngenta, ABB, ...
Gates Medical Research Institute in Cambridge names new head - The Boston Globe
The Boston Globe· 7 days agoA former longtime executive at the Swiss drug giant Novartis will become the new chief executive of...
Novartis reports Phase III data for trials of remibrutinib to treat CSU
Clinical Trials Arena via Yahoo Finance· 4 days agoNovartis has released new data from two Phase III clinical trials confirming the sustained efficacy...
What NC Gov. Cooper says about the economy and politics after European recruitment trip
The News & Observer· 1 hour agoCooper told reporters after a Council of State meeting in downtown Raleigh that he met with more than a dozen companies, including those interested in North Carolina. Cooper traveled to France ...
Campbell hires lawyer to head affordability unit - The Boston Globe
The Boston Globe· 7 days agoA former longtime executive at the Swiss drug giant Novartis will become the new chief executive of...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoKeytruda is the world’s top-selling drug and raked in about $25 billion in revenue for Merck last year. (ben.glickman@wsj.com; @benglickman) 1151 ET –...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have...